Dicopa Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.65 Cr
as on 24-10-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -28.39%
(FY 2023)
- Profit 79.44%
(FY 2023)
- Ebitda -113.17%
(FY 2023)
- Net Worth -0.46%
(FY 2023)
- Total Assets 32.20%
(FY 2023)
About Dicopa Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sudhanshu Tyagi, Ashish Tyagi, and Sarla Tyagi serve as directors at the Company.
- CIN/LLPIN
U74999DL2017PTC313804
- Company No.
313804
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dicopa Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhanshu Tyagi  | Director | 02-Mar-2017 | Current |
Ashish Tyagi  | Director | 12-Jun-2018 | Current |
| Sarla Tyagi | Director | 12-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Dicopa Healthcare.
Dicopa Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.39% decrease. The company also saw a substantial improvement in profitability, with a 79.44% increase in profit. The company's net worth dipped by a decrease of 0.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dicopa Healthcare?
In 2023, Dicopa Healthcare had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himalayan Splendour Resort Private LimitedActive 5 years 8 monthsSudhanshu Tyagi is a mutual person
- Porvoo Home Healthcare Private LimitedActive 7 years 8 months
Sudhanshu Tyagi and Ashish Tyagi are mutual person
- Stratyfi Ventures Private LimitedActive 2 years 6 months
Sudhanshu Tyagi and Ashish Tyagi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dicopa Healthcare?
Unlock and access historical data on people associated with Dicopa Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dicopa Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dicopa Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
